These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17630258)

  • 1. Decreased levels of plasma glutamate in patients with first-episode schizophrenia and bipolar disorder.
    Palomino A; González-Pinto A; Aldama A; González-Gómez C; Mosquera F; González-García G; Matute C
    Schizophr Res; 2007 Sep; 95(1-3):174-8. PubMed ID: 17630258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients.
    Palomino A; González-Pinto A; Martinez-Cengotitabengoa M; Ruiz de Azua S; Alberich S; Mosquera F; Matute C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():29-33. PubMed ID: 23337034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder.
    Dean B; Digney A; Sundram S; Thomas E; Scarr E
    Psychiatry Res; 2008 Feb; 158(1):75-8. PubMed ID: 18096247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free thyroxine levels are associated with cognitive abilities in subjects with early psychosis.
    Barbero JD; Gutiérrez-Zotes A; Montalvo I; Creus M; Cabezas Á; Solé M; Algora MJ; Garcia-Parés G; Vilella E; Labad J
    Schizophr Res; 2015 Aug; 166(1-3):37-42. PubMed ID: 25982813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease and drug effects on internally-generated and externally-elicited responses in first episode schizophrenia and psychotic bipolar disorder.
    Keedy SK; Bishop JR; Weiden PJ; Sweeney JA; Rosen C; Marvin R; Reilly JL
    Schizophr Res; 2014 Oct; 159(1):101-6. PubMed ID: 25112158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bipolar episodes in adolescents: diagnostic issues and follow-up in adulthood].
    Cohen D; Guilé JM; Brunelle J; Bodeau N; Louët E; Lucanto R; Consoli A
    Encephale; 2009 Dec; 35 Suppl 6():S224-30. PubMed ID: 20141776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders.
    Steen NE; Aas M; Simonsen C; Dieset I; Tesli M; Nerhus M; Gardsjord E; Mørch R; Agartz I; Melle I; Ueland T; Spigset O; Andreassen OA
    World J Biol Psychiatry; 2017 Sep; 18(6):471-482. PubMed ID: 27712130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent aripiprazole for schizophrenia.
    Brotzge K; Manshadi M; El-Mallakh RS
    Schizophr Res; 2012 Feb; 134(2-3):302-3. PubMed ID: 22209538
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients.
    Miodownik C; Maayan R; Ratner Y; Lerner V; Pintov L; Mar M; Weizman A; Ritsner MS
    Clin Neuropharmacol; 2011; 34(4):155-60. PubMed ID: 21617527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in [(3)H]-glutamate uptake into platelets from patients with bipolar I disorder.
    do Nascimento CA; Nogueira CW; Borges VC; Rocha JB
    Psychiatry Res; 2006 Mar; 141(3):343-7. PubMed ID: 16499977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes.
    Stevenson JM; Reilly JL; Harris MS; Patel SR; Weiden PJ; Prasad KM; Badner JA; Nimgaonkar VL; Keshavan MS; Sweeney JA; Bishop JR
    Transl Psychiatry; 2016 Feb; 6(2):e739. PubMed ID: 26905411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics and the relevance of glutamate and serotonin.
    van der Heijden FM; Tuinier S; Fekkes D; Sijben AE; Kahn RS; Verhoeven WM
    Eur Neuropsychopharmacol; 2004 May; 14(3):259-65. PubMed ID: 15056486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential use of lurasidone for the treatment of bipolar psychosis.
    Carta MG; Moro MF; Nardi AE; Calabrese JR
    Expert Opin Investig Drugs; 2015 Apr; 24(4):575-84. PubMed ID: 25633339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness.
    Whitty P; Clarke M; McTigue O; Browne S; Gervin M; Kamali M; Lane A; Kinsella A; Waddington J; Larkin C; O'Callaghan E
    Schizophr Res; 2006 Sep; 86(1-3):110-7. PubMed ID: 16765029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder.
    Richardson MA; Read LL; Reilly MA; Clelland JD; Clelland CL
    Neurochem Res; 2007 Jan; 32(1):107-13. PubMed ID: 17160504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study.
    Chen Y; Bobo WV; Watts K; Jayathilake K; Tang T; Meltzer HY
    J Psychopharmacol; 2012 Sep; 26(9):1201-10. PubMed ID: 22234928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium in combination with perphenazine: effect on plasma monoamine metabolites.
    Bowers MB; Mazure CM; Nelson JC; Jatlow PI
    Biol Psychiatry; 1992 Dec; 32(12):1102-7. PubMed ID: 1477190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.
    Goff DC; Coyle JT
    Am J Psychiatry; 2001 Sep; 158(9):1367-77. PubMed ID: 11532718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between weight gain and clinical improvement: is there a metabolic threshold for second generation antipsychotics?
    Sharma E; Rao NP; Venkatasubramanian G; Behere RV; Varambally S; Sivakumar PT; Gangadhar BN
    Psychiatry Res; 2011 Mar; 186(1):155. PubMed ID: 20691482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.